RxDoctor Payments Data

Abdullah Malik, MD

Interventional Cardiology · Merrillville, INNPI 1245680164

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $12,524 of the $18,228 with a category attached, or 68.7%. Philips North America LLC accounts for 71.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $14,372 and has fallen 85.6% since, to $2,068 in 2025.

$18,228in general payments, 2019–2025

Across 80 payments — averaging $227.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$13K
  • Abbott$2K
  • Medtronic$795
  • Abiomed$487
  • Shockwave Medical, Inc$255
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$249
  • plus $2K from 19 others

What the payments were for

  • Travel & lodging$12,52469%
  • Food & beverage$4,49125%
  • Education$1,2127%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,228 in reported general payments places this provider in the 75th percentile of 170 interventional cardiology providers in Indiana.

See all interventional cardiology providers in Indiana

Medicare billing

Part B allowed, 2024
$13,319
Medicare patients
157
Services billed
278

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate21$532
Rosuvastatin Calcium11$369

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Merrillville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →